ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04921	Oxytocin signaling pathway	6/22	209/7206	2.80233955277e-05
ko04713	Circadian entrainment	5/22	136/7206	4.5244705038e-05
ko04020	Calcium signaling pathway	6/22	265/7206	0.000106067326083
ko04261	Adrenergic signaling in cardiomyocytes	5/22	205/7206	0.000314771261813
ko04922	Glucagon signaling pathway	4/22	128/7206	0.000542141837332
ko04728	Dopaminergic synapse	4/22	185/7206	0.00214080977078
ko04970	Salivary secretion	3/22	95/7206	0.00285047933668
ko05010	Alzheimer's disease	4/22	202/7206	0.00294880627071
ko04720	Long-term potentiation	3/22	99/7206	0.00320468083221
ko04925	Aldosterone synthesis and secretion	3/22	105/7206	0.00378499135675
ko04911	Insulin secretion	3/22	117/7206	0.00512927808329
ko04912	GnRH signaling pathway	3/22	122/7206	0.00576440550751
ko04745	Phototransduction - fly	2/22	38/7206	0.00585290129619
ko04270	Vascular smooth muscle contraction	3/22	154/7206	0.0109412856807
ko04725	Cholinergic synapse	3/22	160/7206	0.012135286745
ko00290	Valine, leucine and isoleucine biosynthesis	1/22	4/7206	0.0121587536468
ko04910	Insulin signaling pathway	3/22	172/7206	0.0147427808869
ko04730	Long-term depression	2/22	78/7206	0.0232288034057
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	2/22	79/7206	0.0237884907059
ko04740	Olfactory transduction	2/22	80/7206	0.0243537627374
ko04022	cGMP-PKG signaling pathway	3/22	216/7206	0.0268719708149
ko04924	Renin secretion	2/22	86/7206	0.0278606700393
ko05031	Amphetamine addiction	2/22	91/7206	0.0309301645479
ko03015	mRNA surveillance pathway	2/22	93/7206	0.0321943434438
ko04260	Cardiac muscle contraction	2/22	98/7206	0.0354433537126
ko04971	Gastric acid secretion	2/22	98/7206	0.0354433537126
ko05410	Hypertrophic cardiomyopathy (HCM)	2/22	100/7206	0.0367776766474
ko00770	Pantothenate and CoA biosynthesis	1/22	14/7206	0.0419413289486
ko05414	Dilated cardiomyopathy	2/22	112/7206	0.0451827379144